Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Russian Extreme Hypertriglyceridemia Registry (REGGI)

NCT07508930 is registered in ClinicalTrials.gov with Russian Cardiology Research and Production Center as lead sponsor.

NCT NCT07508930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07508930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Russian Extreme Hypertriglyceridemia Registry (REGGI)
Lead sponsor
Russian Cardiology Research and Production Center
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2025
Completion date
December 31, 2045
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia